Skip to main content
Top
Published in:

11-03-2024 | Osteosarcoma | Case Report

Low-grade central osteosarcoma with extraosseous dedifferentiation: a rare case

Authors: Kengo Kawaguchi, Kenichi Kohashi, Koji Sagiyama, Mikiko Hashisako, Akira Nabeshima, Nokitaka Setsu, Makoto Endo, Takeshi Iwasaki, Yasuharu Nakashima, Yoshinao Oda

Published in: Skeletal Radiology | Issue 12/2024

Login to get access

Abstract

Low-grade central osteosarcoma (LGCOS), which arises from the intramedullary cavity of the metaphysis of long bones, occasionally exhibits extraosseous spread. Approximately 10–30% of patients with LGCOS exhibit dedifferentiation, but it is rare to experience a primary tumor with a dedifferentiated component. A 38-year-old female patient presented with right knee pain for two months. Imaging studies revealed a bone mass with extraosseous involvement. Wide resection was performed, and pathologic examination led to the diagnosis of LGCOS with a dedifferentiated extraosseous lesion. A single defect in the bone cortex constituted the boundary between the low- and high-grade components. The extraosseous high-grade component included more tumor cells with p53 overexpression and more murine double minute 2 (MDM2) copies compared with the low-grade component. These genetic mutations and copy number alterations can be associated with malignant transformation of LGCOS.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Low-grade central osteosarcoma with extraosseous dedifferentiation: a rare case
Authors
Kengo Kawaguchi
Kenichi Kohashi
Koji Sagiyama
Mikiko Hashisako
Akira Nabeshima
Nokitaka Setsu
Makoto Endo
Takeshi Iwasaki
Yasuharu Nakashima
Yoshinao Oda
Publication date
11-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 12/2024
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-024-04647-x

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest